Pr Christophe Massard
- Specialty
- Oncologist, bladder expert, prostate expert
- Title
- Head of the Early Trials Department (DITEP)
- Hospital
- Gustave Roussy (Villejuif)
- Latest articles
-
- Infectious Complications in Patients Treated with T-cell Engagers as Cancer Immunotherapies, A Descriptive Study from the REISAMIC Registry. (Apr 1, 2025)
- Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results. (Mar 17, 2025)
- Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients. (Mar 10, 2025)
- AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: Phase I trial in Patients with Advanced Solid Tumors. (Feb 12, 2025)
- Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World Setting. (Feb 1, 2025)